About

PMC's Annual Award for Leadership in Personalized Medicine


Ellen Sigal, Ph.D., Founder, Chairperson, Friends of Cancer Research, accepts the 14th Annual Award for Leadership in Personalized Medicine from Steven D. Averbuch, M.D., formerly Vice President and Head of Precision Medicine at Bristol-Myers Squibb.

Now Accepting Nominations


The Personalized Medicine Coalition (PMC) is now accepting nominations for the 15th Annual Award for Leadership in Personalized Medicine. The award recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.

PMC will present the award during the 15th Annual Personalized Medicine Conference, which will take place from November 13 - 14 at Harvard Medical School. The recipient will share his or her vision for the future of personalized medicine with conference attendees.

To nominate a leader, please email a letter of nomination explaining how your nominee has advanced personalized medicine along with a brief bio of the nominee to Christopher J. Wells at cwells@personalizedmedicinecoalition.org.

Please note that PMC Board members are ineligible to receive the award.

About the Award


The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.

Previous award recipients include:

  • Ellen V. Sigal, Ph.D. (2018)
    Chairperson, Founder
    Friends of Cancer Research
  • Jay T. Flatley (2017)
    Executive Chairman
    Illumina
  • Raju Kucherlapati, Ph.D. (2016)
    Paul C. Cabot Professor of Genetics
    Harvard Medical School
  • Francis S. Collins, M.D., Ph.D. (2015)
    Director
    National Institutes of Health (NIH)
  • Mark Levin (2014)
    Co-founder, Partner
    Third Rock Ventures
  • Kathy Giusti (2013)
    Founder, Chief Executive Officer
    Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  • Randal W. Scott, Ph.D. (2012)
    Co-Founder
    InVitae Corporation
  • Leroy Hood, Ph.D., M.D. (2011)
    President
    Institute for Systems Biology
  • William S. Dalton, Ph.D., M.D. (2010)
    CEO
    M2GEN
    Director
    DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
  • Brook Byers (2009)
    Managing Partner
    Kleiner Perkins Caufield & Byers (KPCB)
  • Michael O. Leavitt (2008)
    Founder and Chairman
    Leavitt Partners
  • Ralph Snyderman, M.D. (2007)
    Chancellor Emeritus
    Duke University
    Founder and Chairman
    Proventys, Inc.
  • Elizabeth G. Nabel, M.D. (2006)
    President
    Brigham and Women's Health Care
  • Janet Woodcock, M.D. (2005)
    Director
    FDA Center for Drug Evaluation and Research